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Voiding Dysfunction
One-Year Outcomes of Mid-urethral Sling Procedures for Stress 
Urinary Incontinence According to Body Mass Index
In Sung Hwang, Ji Hyeong Yu, Jae Yong Chung, Chung Hee Noh, Luck Hee Sung
Department of Urology, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
Purpose: The purpose of our study was to investigate the safety and efficacy of the supra-
pubic arch (SPARC) sling operation and the transobturator tape (MONARC) sling oper-
ation according to body mass index (BMI).
Materials and Methods: Between January 1, 2004, and July 12, 2009, a retrospective 
clinical trial was performed with 284 patients treated by the SPARC sling procedure 
and 49 patients treated by the MONARC sling procedure. The women were classified 
into 3 groups by BMI according to the WHO Expert Consultation: normal weight (A, 
BMI 18.5 to 22.9 kg/m
2), overweight (B, BMI 23 to 27.5 kg/m
2), and obese (C, BMI＞27.6 
kg/m
2). Patients’ characteristics and clinical outcomes of the operation were analyzed 
according to BMI at 1 year after surgery via questionnaires and interviews with the 
patients about their voiding symptoms and medical records.
Results: There were 103 patients in group A, 186 in group B, and 34 in group C. The 
objective cure rates for groups A, B, and C after the SPARC procedure were 94.4%, 
96.7%, and 96.8%, respectively (p=0.321), and the subjective cure rates were 94.4%, 
96.1%, and 96.8%, respectively (p=0.222). The objective cure rates for groups A, B, and 
C after the MONARC procedure were 100.0%, 90.9%, and 66.7%, respectively (p=0.742), 
and the subjective cure rates were 92.3%, 93.9%, and 66.7%, respectively (p=0.779). 
The complication rates were similar among the three study groups.
Conclusions: Mid-urethral sling procedures for urinary incontinence result in similar 
objective and subjective cure rates and postoperative complications irrespective of BMI. 
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INTRODUCTION
Stress urinary incontinence (SUI) is the most prevalent 
disease in middle-aged women, with an incidence of 30 to 
50% [1]. Obesity is an important risk factor for the develop-
ment of urinary incontinence at an old age in addition to 
vaginal delivery, a history of gynecological surgery, body 
mass index (BMI), menopausal status, smoking, and coffee 
and alcohol consumption [2,3]. Currently, obesity is not 
just a cosmetic problem. Obesity is an increasing health 
problem all over the world that affects as much as 25% of 
the adult population in many countries in Europe, in 
Australia, and in the United States [4]. The Third National 
Health and Nutrition Survey reported in 2001 announced 
that the overall prevalence of obesity (BMI≥  25.0 kg/m
2) 
in Korean adults is 30.6% (32.4% in men and 29.4% in wom-
en) [5]. SUI was proven to be the urinary incontinence type 
most closely associated with BMI [6]. Some have described 
the increase of intra-abdominal pressure in obese patients, 
and this phenomenon may stress the pelvic floor, possibly 
causing nerve and muscular injuries that may lead to a 
higher prevalence of SUI [7,8].
Although weight loss may be beneficial to obese patients 
with SUI, operative interventions remain the best options 
for definitive treatment [9]. A number of techniques for the 
correction of SUI have been described through the years. 
Since the description of the tension-free vaginal tape (TVT) 
procedure in 1996 [10], interest in minimally invasive tech-Korean J Urol 2012;53:171-177
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niques for treating SUI and the attractiveness of such 
treatments to patients have led to a number of mod-
ifications of the TVT procedure, including transobturator 
vaginal tape (TOT) [11] and suprapubic arch sling (SPARC) 
[12]. This kind of surgery is generally considered to have 
the advantages of low morbidity, reduced costs, and shorter 
hospital stay [11,12]. However, there are not many large 
prospective series, and few studies have assessed the out-
come of these procedures in obese women.
The purpose of this study was to assess the potential im-
pact of obesity on the success rate of the MONARC and 
SPARC sling procedures, patient satisfaction, and compli-
cations at 1 year after surgery.
MATERIALS AND METHODS
Between January 2004 and December 2003, 337 consec-
utive women who suffered from SUI underwent either the 
SPARC or the TOT procedure in our institute, and this 
study analyzed 323 of the patients who had been followed 
up for at least 1 year. The patients were classified into three 
groups by BMI according to the World Health Organization 
Expert Consultation: the normal-weight group (A, BMI 
18.5 to 22.9 kg/m
2), the overweight group (B, BMI 23 to 27.5 
kg/m
2), and the obese group (C, BMI＞27.6 kg/m
2) [13]. The 
success rate of the procedures and the patients’ satisfaction 
with the procedures were assessed after 1 year through 
questionnaires, interviews with the patients, and medical 
records. All the patients were preoperatively evaluated 
through the review of their medical history, physical ex-
aminations, and urinalysis and urodynamic studies in-
cluding the measurement of Valsalva leak point pressure 
(VLPP). The severity of urinary incontinence was classi-
fied by the Stamey grade as grade I for women who lost 
urine only with coughing, sneezing, or lifting heavy objects; 
grade II for those who lost urine with minimal activities 
such as walking or arising from the sitting position; and 
grade III for those who were totally incontinent in the up-
right position [14]. Patients with previous failed anti-in-
continence surgeries or treatments with bulking agent 
were also eligible for the study. Patients with mixed uri-
nary incontinence were not excluded as far as their cys-
tometrogram showed normal capacity, compliance, and no 
uninhibited contractions. Patients with obstructive, un-
stable bladder functions or neurogenic bladders were ex-
cluded from the study.
All surgeries were performed with the patient in the lith-
otomy position under general anesthesia or spinal anes-
thesia. After the bladder was voided by inserting a cathe-
ter, a median incision was made around 2.0 cm long along 
the mid-urethra from the lower portion of the external or-
ifice of the urethra on the anterior vaginal wall, and tissue 
on both sides around the urethra was detached through the 
incision. In the SPARC procedure, 1-cm long skin incisions 
were made on both sides of the superior pubis, and SPARC 
needles were inserted so that the needle tip went through 
the posterior surface of the pubis and came out to the in-
cision on the anterior vaginal wall. In the MONARC proce-
dure, an incision was made on the obtuator foramen, and 
a tunnel was inserted through the rear side of the ischio-
pubic ramus in the direction of 45
o from the horizontal and 
vertical planes so that its end came out to the incision site 
on the vagina. The same method was applied to both sides 
so that the two needle ends were positioned in the incision 
sites on the anterior vaginal wall, and cystoscopy was per-
formed to see if there was any injury in the bladder or the 
urethra. Tape was connected to the two needle tips, and 
Mayo scissors were hung on the tape so that tensile force 
was not applied. In this state, the tape was pulled from the 
outer area of the superior pubis and the obtuator foramen 
so that it was positioned at around the mid-urethra. In cas-
es in which no bladder perforations occurred during the op-
eration, the catheter was removed on day 2 to 3 and 
self-voiding was tried. If bladder perforation occurred, the 
catheter was maintained for 7 to 10 days and was then re-
moved and self-voiding was tried. If self-voiding failed or 
the quantity of residual was over 100 ml, intermittent 
self-catheterization was performed. If the symptoms were 
not improved even with intermittent self-catheterization, 
urethral dilatation was performed, or within 1 month from 
the surgery the tensile force of the tape was adjusted under 
local anesthesia. Postoperative cure or improvement was 
defined according to Stamey’s criteria [10]. “Cure” meant 
a state without urinary incontinence at all; “improvement” 
meant a state in which no particular treatment was neces-
sary because urinary incontinence was quite rare or the pa-
tient was highly satisfied with the outcome of the surgery; 
and “failure” meant a state in which the severity of urinary 
incontinence had not changed after surgery or the patient 
was not satisfied with the outcome of surgery. The objective 
success rate included both cure and improvement. The lev-
el of satisfaction with the outcome of surgery was graded 
as “satisfied,” “fair,” or “dissatisfied,” and the subjective 
success rate included “satisfied” and “fair.” In addition, we 
assessed the objective success rate and the subjective suc-
cess rate in patients with mixed urinary incontinence, and 
investigated the safety of the SPARC procedure and the 
MONARC procedure by comparing the incidence of post-
operative complications. The results of this study were 
processed statistically through independent-sample Stu-
dent’s t-tests and one-way analysis of variance, and stat-
istical significance was considered if p＜0.05.
RESULTS
The numbers of patients in the normal-weight group, over-
weight group, and obese group were 103, 186, and 34, re-
spectively, and the patients’ mean ages were 49.23±7.90, 
50.42±8.14, and 52.15±6.53 years, respectively (p=0.873). 
The mean numbers of childbirths were 2.17±0.85, 2.38±0.84, 
and 2.32±0.91 (p=0.138); the patients’ mean BMIs were 
21.51±1.11 kg/m
2, 24.8±1.24 kg/m
2, and 29.64±2.17 kg/m
2 
(p＜0.001); the mean preoperative maximum urine flow 
rates were 28.88±10.99 ml/s, 30.30±9.96 ml/s, and 33.44± Korean J Urol 2012;53:171-177
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TABLE 1. Characteristics of patients undergoing the mid-urethral sling procedure according to body mass index
Characteristics Normal group Overweight group Obese group p-value
Number
Mean age (yr)
Mean body weight (kg)
Mean height (m)
Mean BMI (kg/m
2)
Mean parity (no.)
Mean preoperative Qmax (ml/s)
Mean preoperative residual urine (ml)
Mean preoperative VLPP (cm/H2O)
Preoperative symptom severity
Stamey grade (%)
    I
    II
    III
Presence of cystocele
Chronic disease
    Hypertension (%)
    DM (%)
    Previous pelvic surgery (%)
    Previous anti-incontinence surgery (%)
Type of procedure
    SPARC (%)
    MONARC (%)
103
49.23±7.90
53.22±4.23
  1.57±0.05
21.52±1.14
  2.17±0.85
  28.88±10.99
  18.84±19.41
  70.90±27.14
79 (76.7)
22 (21.4)
2 (1.9)
9 (8.7)
16 (15.5)
7 (6.8)
12 (11.7)
2 (1.9)
90 (87.4)
13 (12.6)
186
50.42±8.14
60.87±4.85
  1.57±0.05
  24.8±1.24
  2.38±0.84
30.30±9.96
  20.91±33.72
  68.81±29.80
120 (64.5)
  58 (31.2)
  8 (4.3)
  21 (11.3)
  30 (16.1)
11 (5.9)
  36 (19.4)
  4 (2.2)
153 (82.3)
  33 (17.7)
34
52.15±6.53
72.49±6.27
  1.56±0.46
29.64±2.17
  2.32±0.91
  33.44±14.94
  22.71±34.27
  64.97±23.70
22 (64.7)
11 (32.4)
1 (2.9)
3 (8.8)
14 (41.2)
  7 (20.6)
  7 (20.6)
2 (5.9)
31 (91.2)
3 (8.8)
-
0.156
＜0.001
0.455
＜0.001
0.138
0.106
0.767
0.562
0.088
0.761
0.002
a
0.012
a
0.149
0.402
0.283
BMI, body mass index; Qmax, maximum urinary flow rate; VLPP, Valsalva leakage point pressure; DM, diabetic mellitus; SPARC, 
suprapubic arch sling procedure; MONARC, transobturator tape procedure.
a: p＜0.05, statistically significant.
14.94 ml/s (p=0.106); and the mean preoperative VLPPs 
were 70.90±27.14 cm/H2O, 68.81±29.80 cm/H2O, and 
64.97±23.70 cm/H2O (p=0.562). Concerning the history of 
hypertension and diabetes in the groups, the nor-
mal-weight, overweight, and obese groups had, re-
spectively, 16, 30, and 14 hypertensive patients (p=0.002) 
and 7, 11, and 7 patients with diabetes (p=0.012). In addi-
tion, there were, respectively, 12, 36, and 7 patients with 
a history of pelvic surgery and 2, 4, and 2 patients with a 
history of surgery for urinary incontinence. When pre-
operative patient characteristics were compared among 
the groups, no statistically significant differences were ob-
served except for the history of hypertension and diabetes 
(Table 1). When the postoperative objective success rate 
and subjective success rate were compared among the 
groups, the objective success rates of the sling operation 
were 95.1% (98/103), 95.7% (178/186), and 94.1% (32/34), 
respectively, in the normal-weight, overweight, and obese 
groups (p=0.288), and the subjective success rates were 
94.2% (97/103), 95.7% (178/186), and 94.1% (32/34) (p=0.163). 
The objective success rates of the SPARC procedure were 
94.4% (85/90), 96.7% (148/153), and 96.8% (30/31) (p=0.321), 
and the subjective success rates were 94.4% (85/90), 96.1% 
(147/153), and 96.8% (30/31) (p=0.222). The objective suc-
cess rates of the MONARC procedure were, respectively, 
100.0% (13/13), 90.9% (30/33), and 66.7% (2/3) (p=0.742), 
and the subjective success rates were 92.3% (12/13), 93.9% 
(31/33), and 66.7% (2/3) (p=0.779). The differences in the 
success rates according to BMI were not statistically sig-
nificant (Tables 2-4). In addition, 34, 70, and 16 patients 
in each group, respectively, had mixed incontinence and 
the objective success rates and subjective success rates 
were, respectively, 91.2% (31/34), 90.0% (63/70), and 
100.0% (16/16) (p=0.183) and 91.2% (31/34), 88.6% (62/70), 
and 100.0% (16/16) (p=0.139). These differences among the 
groups were not statistically significant (Table 5). 
Concerning postoperative complications, the normal-wei-
ght group had one case of bladder injury, three of acute uri-
nary retention, and two of urinary urgency; the overweight 
group had one case of bladder injury, two of urinary re-
tention, and one of urinary urgency; and the obese group 
had one case of urinary retention and one of urinary 
urgency. On the whole, no significant differences were ob-
served in the incidence of complications among the groups 
(p=0.441) (Table 6).
DISCUSSION
Obesity is a well-established risk factor for the develop-
ment of SUI and may impact the voiding pattern, but the 
exact mechanism of this effect is not clear. Higher intra-ab-
dominal pressure has been observed in patients with high-
er BMI, and this may stress the pelvic floor secondary to 
a chronic state of increased pressure [7]. Mommsen and Korean J Urol 2012;53:171-177
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TABLE 2. Objective and subjective success rates after the sling operation according to BMI group
Normal group (n=103) Overweight group (n=186) Obese group (n=34) p-value
Cure rate (objective)
    Total (%)
        SPARC (%)
        MONARC (%)
Cure rate (subjective)
    Total (%)
        SPARC (%)
        MONARC (%)
98 (95.1) 
85 (94.4)
13 (100)
97 (94.2)
85 (94.4)
12 (91.3)
178 (95.7)
148 (96.7)
  30 (90.9)
178 (95.7)
147 (96.1)
  31 (93.9)
32 (94.1)
30 (95.8)
  2 (66.7)
32 (94.1)
30 (95.8)
  2 (66.7)
0.321
0.742
0.222
0.779
BMI, body mass index; SPARC, suprapubic arch sling procedure; MONARC, transobturator tape procedure.
a: p＜0.05, statistically significant.
TABLE 4. Objective and subjective success rates after MONARC according to BMI group
Outcome Normal group (n=13) Overweight group (n=33) Obese group (n=3) p-value
Objective
    Success (%)
        Cure (%)
        Improvement (%)
    Failure (%)
Subjective
    Success (%)
        Satisfied (%)
        Fair (%)
    Dissatisfied (%)
13 (100) 
8 (61.5)
5 (38.5)
0
12 (91.3)
  9 (69.2)
  3 (23.1)
1 (7.7)
30 (90.9)
24 (72.7)
  6 (18.2)
3 (9.1)
31 (93.9)
22 (66.7)
  9 (27.2)
2 (6.1)
2 (66.7)
1 (33.3)
1 (33.3)
1 (33.3)
2 (66.7)
1 (33.3)
1 (33.3)
1 (33.3)
0.742
0.779
BMI, body mass index; MONARC, transobturator tape procedure.
a: p＜0.05, statistically significant.
TABLE 3. Objective and subjective success rates after SPARC according to BMI group
Outcome Normal group (n=90) Overweight group (n=153) Obese group (n=31) p-value
Objective
    Success 
        Cure (%)
        Improvement (%)
    Failure (%)
Subjective
    Success (%)
        Satisfied (%)
        Fair (%)
    Dissatisfied (%)
85 (94.4) 
68 (75.5)
17 (18.9)
5 (5.6)
85 (94.4)
62 (68.8)
23 (25.6)
5 (5.6)
148 (96.7)
127 (83.0)
  21 (13.7)
  5 (3.3)
147 (96.1)
118 (77.1)
  29 (19.0)
  6 (3.9)
30 (95.8)
26 (83.9)
  4 (12.9)
1 (3.2)
30 (95.8)
26 (83.9)
  4 (12.9)
1 (3.2)
0.321
0.222
BMI, body mass index; SPARC, suprapubic arch sling procedure.
a: p＜0.05, statistically significant.
Foldspang investigated 2,589 women aged 30 to 59 years 
and reported that, independently of other risk factors, BMI 
and the incidence of urinary incontinence in women were 
positively correlated with each other and, among the types 
of urinary incontinence, BMI was most closely related to 
SUI [15]. Increased intra-abdominal pressure elevates 
pressure at the maximum cystometric capacity and de-
creases cough pressure transmission from the bladder to 
the urethra, in addition to decreasing VLPP, which may 
contribute to the development of SUI in obese patients [16]. 
On the other hand, obesity-induced neurogenic effects on 
the pelvic floor may also contribute to the development of 
urgency or urge incontinence [16]. However, in our data, 
we found no significant differences in VLPP, the grade of 
SUI, and urgency and urge incontinence. The results of a 
study of a Korean population by Ku et al. [17] agree with 
our data. We believe that obesity was defined by a BMI of 
30 or higher in the Western population studied in the pre-Korean J Urol 2012;53:171-177
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TABLE 5. Objective and subjective success rates in patients with mixed urinary incontinence patients according to BMI group
Operation Outcome
Normal group 
(n=34)
Overweight group 
(n=70)
Obese group 
(n=16)
p-value
SPARC＋MONARC
SPARC
MONARC
Success (%)
Satisfaction (%)
Success (%)
Satisfaction (%)
Success (%)
Satisfaction (%)
31 (91.2)
31 (91.2)
26 (89.7)
58 (95.1)
    5 (100.0)
  4 (80.0)
63 (90.0)
62 (88.6)
51 (91.1)
50 (89.3)
12 (85.7)
12 (85.7)
16 (100.0)
16 (100.0)
15 (100.0)
15 (100.0)
  1 (100.0)
  1 (100.0)
0.183
0.139
0.291
0.189
0.733
0.539
BMI, body mass index; SPARC, suprapubic arch sling procedure; MONARC, transobturator tape procedure.
a: p＜0.05, statistically significant.
TABLE 6. Postoperative complications according to BMI group
Complications Normal group (n=103) Overweight group (n=186) Obese group (n=34) p-value
Bladder perforation
Urinary retention
Urinary urgency
Bleeding
Vaginal erosion
Total (%)
1
3
2
0
0
6 (3.9)
1
2
1
0
0
4 (2.2)
0
1
1
0
0
2 (5.9) 0.441
BMI, body mass index.
a: p＜0.05, statistically significant.
vious report, and this may make a difference in the results.
The treatments of SUI are largely divided into non-
surgical and surgical treatments. Nonsurgical treatments 
include drug therapy and physical therapies such as pelvic 
floor exercise, biofeedback therapy, and electrical stim-
ulation therapy. These treatments are applicable when 
symptoms are mild or the patient cannot endure surgery 
and are less invasive and less costly than surgical ones. 
However, these treatments have a low cure rate and re-
quire the patient’s high compliance and, in this sense, their 
expected effect is lower than that of surgical treatments. 
For this reason, surgical treatments are commonly used for 
SUI. It is generally known that, for obese patients, surgery 
through the incision of the abdominal pelvic part increases 
the incidence of complications and is difficult to perform 
[18,19]. This is also the case in surgical treatment for obese 
women with SUI. For example, Burch vaginal suspension 
and Marshall-Marchetti-Krantz cystourethropexy are in-
vasive procedures with a large incision site. According to 
the report of O'Sullivan et al. [20] when obese women who 
had bladder neck suspension were followed up for 5 years, 
the failure rate was significantly higher than that in nor-
mal-weight women. Moreover, Varner reported that among 
SUI patients who underwent retropubic bladder neck sus-
pension, 3 patients experienced recurrence after the sur-
gery and all of them were obese [21]. Those authors sug-
gested that the result was evidence that obesity may in-
crease intraabdominal and pelvic pressure and cause the 
failure of surgery [21]. On the other hand, however, Parnell 
et al. [18] reported that 2 obese patients were cured among 
151 SUI patients treated through the Marshall-Marchet-
ti-Krantz procedure, and Harris et al. [19] reported that 
they performed anterior colpopexy or retropubic urethro-
pexy for SUI patients and that obesity did not affect the out-
come of the procedures. In these ways, reports are not con-
sistent on the outcomes of invasive procedures for urinary 
incontinence in obese patients. 
In 1996, Ulmsten et al. [10] described TVT, a kind of 
modified sling procedure, which has since been applied to 
many patients with SUI with long-term follow-up results 
that have been reported to be satisfactory. The modified 
sling procedure began to be used for obese women as a sub-
stitute for previous invasive surgery, and several reports 
have been made on the postoperative success rates of the 
procedure. Cummings et al. [22] performed transvaginal 
bladder neck suspension in 4 of 16 obese women and the 
sling procedure in the other 12. Failure occurred in two of 
the patients who underwent transvaginal bladder neck 
suspension but in none of the patients who underwent the 
sling procedure. When addressing this result, the authors 
explained that the sling procedure supports the tissue 
around the urethra without suturing, and because this tis-
sue is already weak and easily torn, it is more durable to 
correction by the sling procedure than by transvaginal 
bladder neck suspension. On the basis of this explanation, 
those authors argued that the sling procedure is the best 
treatment for SUI in obese women [22]. Later, the SPARC 
procedure was developed and has been used since 2001. 
The basic principle of the SPARC procedure is the same, 
but the approach used is opposite to that of the TVT proce-
dure, with the anterior vaginal wall being accessed from 
the superior pubis. Kim et al. [23] reported this procedure Korean J Urol 2012;53:171-177
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to be equally effective and safe for the surgical treatment 
of female SUI. In addition, the TOT procedure had been de-
veloped, in which the anterior vaginal wall is accessed 
through the obturator foramen, which differs from the TVT 
procedure, which uses the retropubic route [11,24]. This 
procedure is a safe and effective treatment for women with 
SUI, and is comparable with TVT. Lee et al. [25] noted that 
the cure rate of the TOT procedure was 92% and the sat-
isfaction rate was 98%. These new procedures reduce sur-
gery-induced wounds because the incision and the detach-
ment of the vaginal wall are not large; consequently, hospi-
tal stay is shortened and management after discharge is 
simple. For obese patients, the minimal size of the incision 
reduces the risk and simplifies the surgical technique. 
There have been a number of reports about the success rate 
of TVT surgery in obese patients, and the consensus is that 
obesity does not influence the outcomes of TVT. 
Recently, the SPARC procedure and the TOT procedure 
are producing good results in the treatment SUI patients, 
but not many reports have been made on their effect in 
obese patients. Ku et al. [17] performed the TVT and SPARC 
sling procedures and confirmed the feasibility and safety 
of the SPARC procedure when applied to obese women who 
suffer from SUI. In addition, Rechberger et al. [26] con-
ducted 269 retropubic and 268 transobturator sling proce-
dures and demonstrated that BMI does not influence the 
clinical effectiveness of SUI treatment. In our study as well, 
the difference in the success rate according to BMI was not 
statistically significant, and the success rate differed little 
among the different types of surgery conducted in our 
hospital. However, to evaluate the exact influence of obe-
sity on sling operation outcomes, long-term follow-up is 
needed. Moreover, it was reported recently that the success 
rate was high not only in obese patients with SUI but also 
in those with mixed urinary incontinence. In 1998, Ulms-
ten et al. [27] reported a cure rate of 91% and an improve-
ment rate of 7% among 131 SUI patients. In 2000, Moran 
et al. [28] reported an objective cure rate of 95% and a sub-
jective cure rate of 80% in 40 patients. In our study as well, 
the objective cure rate and the subjective cure rate were 
91.6% and 90.8%, respectively, in patients with mixed uri-
nary incontinence, and the differences in the rates accord-
ing to BMI were not statistically significant. This suggests 
that both the SPARC procedure and the TOT procedure are 
sufficiently effective also for patients with mixed urinary 
incontinence. 
Various postoperative complications have been reported 
including bladder perforation, intestinal perforation, uri-
nary tract infection, bleeding, hematoma, transient uri-
nary retention, and newly developed de novo urgency, but 
the incidence of such complications is known to be low. 
According to recent reports on postoperative complica-
tions, however, Rafii et al. [8] reported that they performed 
the TVT procedure for 147 normal-weight or overweight 
patients and 38 obese patients and found no significant dif-
ference in the cure rate among the patient groups according 
to BMI, although the incidence of de novo urgency was high-
er in the obese group than in the normal-weight group. 
Also, Sung et al. [29] performed a meta-analysis of TVT and 
transobturator approach studies and concluded that the 
transobturator sling operation had a lower risk (odds ratio: 
0.54) of de novo bladder voiding symptoms than did the TVT 
procedure. In our study, 2 cases of bladder perforation, 6 
of transient urinary retention, and 4 of de novo urgency oc-
curred among 323 patients, but the differences in the in-
cidence of complications according to operative procedure 
or BMI were not statistically significant. Moreover, there 
were no major complications that required laparotomy or 
massive transfusion, and the complications that occurred 
were all improved through conservative treatment or the 
administration of anticholinergics. Accordingly, both of 
the two procedures are believed to be effective and safe re-
gardless of BMI. 
CONCLUSIONS
In this study, the SPARC sling operation and the MONARC 
sling operation showed similar subjective cure rates, pa-
tient satisfaction, and incidence of postoperative complica-
tions regardless of BMI and were also effective for patients 
with mixed urinary incontinence at the 1-year follow-up. 
Accordingly, these sling procedures are believed to be safe-
ly applicable to overweight and obese women, although lon-
ger-term follow-up is needed. Moreover, efforts should be 
made to choose an operative procedure suitable for the con-
dition of the patients through continuous large-scale 
studies.
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